Long-Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.70174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Claudia Pauciulo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Neurology Center, Rome, Italy. Hauptthemen laut MEDLINE: Cat Diseases, Fluoxetine, Behavior Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hyperesthesia syndrome (HS) is a common yet poorly understood condition in cats, with hypothesized neurological and behavioral causes and limited data on outcomes and treatment.
Objectives
This study aimed to describe the clinical outcomes and the treatment response of 28 cats with HS, managed through various therapeutic strategies. Animals Clinical records of 28 cats with HS and minimum of 1-year follow-up were reviewed.
Methods
Retrospective, observational, descriptive study conducted on a case series of cats affected by HS. Sixteen cats (57%) received fluoxetine alone (Fluoxetine-only), seven (25%) were managed with behavioral modification and gabapentin or fluoxetine (Fluoxetine/Gabapentin + Behavior) and five (18%) were treated with behavioral modification alone (Behavior-only).
Results
An episode-free period (EFP) ≥ 9 months was observed in 23 (82%) cats. Fifteen cats (94%) in the Fluoxetine-only group experienced an EFP of ≥ 9 months. Moreover, they had a shorter time to recovery (median [IQR] = 8 [3.5–18] days) compared to the Fluoxetine/Gabapentin + Behavior and Behavior-only groups (median [IQR] = 100 [90–210] and 60 [30–90] days, respectively). At the 1-year follow-up, 26 (93%) cats no longer had HS clinical signs and 14 (50%) were still under pharmacotherapy. Relapses were reported only in one case (4%).
Conclusions
Most of the cat's diagnosed with HS, and managed through various therapeutic strategies, experienced an EFP of more than 9 months and showed absence of clinical signs at 1 year follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Veterinary Neurology Center, Rome, Italy.
- Behavioral Medicine and Animal Welfare Division, San Marco Veterinary Clinic and Laboratory, Veggiano, Italy.
- Department of Veterinary Medicine, Veterinary Teaching Hospital, University of Sassari, Sassari, Italy.
- Veterinary Neurological Center "La Fenice", Selargius, Italy.
- Neurology and Neurosurgery Division, San Marco Veterinary Clinic and Laboratory, Veggiano, Italy.
ORCID-Profile: Andrea Corda
Zitieren
APA
Pauciulo, C., Uccheddu, S., Corda, A., Biggio, F., Corlazzoli, D. S., Menchetti, M., & Gallucci, A. (2025). Long-Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70174
Vancouver
Pauciulo C, Uccheddu S, Corda A, Biggio F, Corlazzoli DS, Menchetti M, et al. Long-Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70174
BibTeX
@article{Pauciulo2025,
author = {Pauciulo, Claudia and Uccheddu, Stefania and Corda, Andrea and Biggio, Federica and Corlazzoli, Daniele Sebastian and Menchetti, Marika and Gallucci, Antonella},
title = {Long-Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.70174}
}
EUVIMED